SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-03-11 13:08
Tx date 2026-03-08 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Warrants
55 - Expiration of warrants
-3,125 vol 		0
Filed 2025-12-22 13:42
Tx date 2025-12-15 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$172,600
+20,000 vol
$8.63 each 		260,000
Filed 2025-12-22 13:40
Tx date 2025-12-15 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights 		$86,300
+10,000 vol
$8.63 each 		10,000
Filed 2025-12-22 11:45
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2025-09-30 10:34
Tx date 2025-09-23 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$13,557
+2,465 vol
$5.50 each 		8,715
Filed 2025-09-30 10:32
Tx date 2025-09-23 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$13,557
+2,465 vol
$5.50 each 		10,145
Filed 2025-06-17 14:44
Tx date 2025-06-16 		$N/A
enGene Holdings Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$74,475
+22,500 vol
$3.31 each 		108,261
Filed 2025-03-26 14:15
Tx date 2025-03-25 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$231,300
+45,000 vol
$5.14 each 		240,000
Filed 2024-05-24 00:26
Tx date 2024-05-13 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$178,200
+45,000 vol
$3.96 each 		195,000
Filed 2024-05-24 00:23
Tx date 2024-05-13 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$178,200
+45,000 vol
$3.96 each
Filed 2024-04-24 18:53
Tx date 2024-04-24 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$18,375
+3,750 vol
$4.90 each 		43,240
Filed 2024-04-24 18:52
Tx date 2024-04-24 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-18,375
-3,750 vol
$4.90 each 		203,250
Filed 2024-03-27 16:24
Tx date 2024-03-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$632,799
+70,000 vol
$9.04 each 		207,000
Filed 2023-08-20 13:03
Tx date 2023-08-18 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,010
+1,430 vol
$7.00 each 		7,680
Filed 2022-12-13 15:22
Tx date 2022-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$57,750
+15,000 vol
$3.85 each 		150,000
Filed 2022-10-27 13:25
Tx date 2022-06-29 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		137,000
Filed 2021-12-15 15:17
Tx date 2021-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$20,200
+10,000 vol
$2.02 each 		135,000
Filed 2021-03-10 17:27
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		6,250
Filed 2021-03-10 17:24
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		6,250
Filed 2021-03-10 17:24
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report